Digital Endpoints: How Sensors and Gamification Improve Clinical Trials
Digital endpoints enable continuous, objective, and remote patient monitoring through sensors and wearables, improving data quality and the patient experience in clinical trials.
GDPR Compliance in Clinical Trials: The Role of EDC Systems
Learn how EDC systems play a vital role in GDPR compliance for clinical trials, supporting data security, audit trails, and participant consent management.
Strategies for Retention, Compliance, and Data Quality in Clinical Trials
Learn how to solve retention, compliance, and data quality challenges in clinical trials, drawing insights from our eBook.
How Gamification Can Keep Clinical Trial Participants Engaged and Motivated
Adapted from a Clinical Trials Arena article, this piece explores how gamification enhances clinical trial engagement, with insights from Replior CEO Christer Nilsson.
Digital Endpoint: Redefining Data Collection in Clinical Trials
Digital endpoints enable continuous, objective, and remote patient monitoring through sensors and wearables, improving data quality and the patient experience in clinical trials.
How to Choose the Right ePRO Software
Download our expert guide to selecting the right ePRO tool for clinical trials. Enhance patient engagement, ensure data accuracy, and make informed decisions with our practical checklist.
OCT Conference Reflections: Embracing Gamification for Patient Engagement
Digital endpoints enable continuous, objective, and remote patient monitoring through sensors and wearables, improving data quality and the patient experience in clinical trials.
Lighting the Way
How Replior’s integrated UV monitoring improves patient engagement in the Almirall AKtive trial, a phase IV study.
Advancing Cardiovascular Research with Trial Online EDC
The SCAPIS study collected and analyzed 30+ million data points from 30,154 participants with Replior.
Message from the CEO: Year in Review 2023
Reflecting on 2023, this CEO message highlights Replior’s achievements, lessons learned, and steps taken to prepare for future growth and innovation in clinical trials.